Itraconazole Methoxy Isopropyltriazolone Impurity

Itraconazole Methoxy Isopropyltriazolone Impurity is a synthetic byproduct arising from the triazole ring formation pathway in itraconazole synthesis. Its structure incorporates a methoxy-substituted isopropyltriazolone moiety, differing from the parent drug by a branched isopropyl substitution at the triazole ring's 4-position and a methoxy group at the piperazine nitrogen. This impurity exhibits reduced antifungal activity due to steric hindrance from the isopropyl group, which disrupts optimal binding to cytochrome P450 enzymes. It serves as a critical HPLC reference standard for quantifying process-related impurities in itraconazole active pharmaceutical ingredient batches.